Global and Japan Premature Ejaculation Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 08-Sep-2021
No. of pages: 109
Inquire Before Buying

Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.

Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.

Market Analysis and Insights: Global Premature Ejaculation Treatment Market

The global Premature Ejaculation Treatment market size is projected to reach US$ 4864.3 million by 2027, from US$ 2646 million in 2020, at a CAGR of 9.2% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Premature Ejaculation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Premature Ejaculation Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Premature Ejaculation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Premature Ejaculation Treatment market.

Global Premature Ejaculation Treatment Scope and Market Size

Premature Ejaculation Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Premature Ejaculation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Antidepressants(SSRIs)

- Phosphodiesterase-5 Inhibitors

- Topical Anesthetics

- Analgesics

- Other Treatment

Segment by Distribution Channel

- Hospital

- Retail Pharmacy

- Online Pharmacy

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Pfizer

- Novartis

- Eli Lilly

- Johnson & Johnson

- GlaxoSmithKline

- Bayer

- Menarini

- Teva

- Sunrise Pharma

- Regent Pacific

- Torrent Pharma

- Vivus

Global and Japan Premature Ejaculation Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antidepressants(SSRIs)
1.2.3 Phosphodiesterase-5 Inhibitors
1.2.4 Topical Anesthetics
1.2.5 Analgesics
1.2.6 Other Treatment
1.3 Market by Application
1.3.1 Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Premature Ejaculation Treatment Market Perspective (2016-2027)
2.2 Premature Ejaculation Treatment Growth Trends by Regions
2.2.1 Premature Ejaculation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Premature Ejaculation Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Premature Ejaculation Treatment Industry Dynamic
2.3.1 Premature Ejaculation Treatment Market Trends
2.3.2 Premature Ejaculation Treatment Market Drivers
2.3.3 Premature Ejaculation Treatment Market Challenges
2.3.4 Premature Ejaculation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Premature Ejaculation Treatment Players by Revenue
3.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2016-2021)
3.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Premature Ejaculation Treatment Revenue
3.4 Global Premature Ejaculation Treatment Market Concentration Ratio
3.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premature Ejaculation Treatment Revenue in 2020
3.5 Premature Ejaculation Treatment Key Players Head office and Area Served
3.6 Key Players Premature Ejaculation Treatment Product Solution and Service
3.7 Date of Enter into Premature Ejaculation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Premature Ejaculation Treatment Breakdown Data by Type
4.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2016-2021)
4.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2022-2027)
5 Premature Ejaculation Treatment Breakdown Data by Distribution Channel
5.1 Global Premature Ejaculation Treatment Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2022-2027)
6 North America
6.1 North America Premature Ejaculation Treatment Market Size (2016-2027)
6.2 North America Premature Ejaculation Treatment Market Size by Type
6.2.1 North America Premature Ejaculation Treatment Market Size by Type (2016-2021)
6.2.2 North America Premature Ejaculation Treatment Market Size by Type (2022-2027)
6.2.3 North America Premature Ejaculation Treatment Market Size by Type (2016-2027)
6.3 North America Premature Ejaculation Treatment Market Size by Distribution Channel
6.3.1 North America Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021)
6.3.2 North America Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027)
6.3.3 North America Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2027)
6.4 North America Premature Ejaculation Treatment Market Size by Country
6.4.1 North America Premature Ejaculation Treatment Market Size by Country (2016-2021)
6.4.2 North America Premature Ejaculation Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Premature Ejaculation Treatment Market Size (2016-2027)
7.2 Europe Premature Ejaculation Treatment Market Size by Type
7.2.1 Europe Premature Ejaculation Treatment Market Size by Type (2016-2021)
7.2.2 Europe Premature Ejaculation Treatment Market Size by Type (2022-2027)
7.2.3 Europe Premature Ejaculation Treatment Market Size by Type (2016-2027)
7.3 Europe Premature Ejaculation Treatment Market Size by Distribution Channel
7.3.1 Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2027)
7.4 Europe Premature Ejaculation Treatment Market Size by Country
7.4.1 Europe Premature Ejaculation Treatment Market Size by Country (2016-2021)
7.4.2 Europe Premature Ejaculation Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2016-2027)
8.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Type
8.2.1 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Distribution Channel
8.3.1 Asia-Pacific Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Region
8.4.1 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Premature Ejaculation Treatment Market Size (2016-2027)
9.2 Latin America Premature Ejaculation Treatment Market Size by Type
9.2.1 Latin America Premature Ejaculation Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Premature Ejaculation Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Premature Ejaculation Treatment Market Size by Type (2016-2027)
9.3 Latin America Premature Ejaculation Treatment Market Size by Distribution Channel
9.3.1 Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2027)
9.4 Latin America Premature Ejaculation Treatment Market Size by Country
9.4.1 Latin America Premature Ejaculation Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Premature Ejaculation Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2016-2027)
10.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Type
10.2.1 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Distribution Channel
10.3.1 Middle East & Africa Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country
10.4.1 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Premature Ejaculation Treatment Introduction
11.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Premature Ejaculation Treatment Introduction
11.2.4 Novartis Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Premature Ejaculation Treatment Introduction
11.3.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Premature Ejaculation Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Premature Ejaculation Treatment Introduction
11.6.4 Bayer Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Menarini
11.7.1 Menarini Company Details
11.7.2 Menarini Business Overview
11.7.3 Menarini Premature Ejaculation Treatment Introduction
11.7.4 Menarini Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.7.5 Menarini Recent Development
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Premature Ejaculation Treatment Introduction
11.8.4 Teva Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.8.5 Teva Recent Development
11.9 Sunrise Pharma
11.9.1 Sunrise Pharma Company Details
11.9.2 Sunrise Pharma Business Overview
11.9.3 Sunrise Pharma Premature Ejaculation Treatment Introduction
11.9.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.9.5 Sunrise Pharma Recent Development
11.10 Regent Pacific
11.10.1 Regent Pacific Company Details
11.10.2 Regent Pacific Business Overview
11.10.3 Regent Pacific Premature Ejaculation Treatment Introduction
11.10.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.10.5 Regent Pacific Recent Development
11.11 Torrent Pharma
11.11.1 Torrent Pharma Company Details
11.11.2 Torrent Pharma Business Overview
11.11.3 Torrent Pharma Premature Ejaculation Treatment Introduction
11.11.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.11.5 Torrent Pharma Recent Development
11.12 Vivus
11.12.1 Vivus Company Details
11.12.2 Vivus Business Overview
11.12.3 Vivus Premature Ejaculation Treatment Introduction
11.12.4 Vivus Revenue in Premature Ejaculation Treatment Business (2016-2021)
11.12.5 Vivus Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antidepressants(SSRIs)
Table 3. Key Players of Phosphodiesterase-5 Inhibitors
Table 4. Key Players of Topical Anesthetics
Table 5. Key Players of Analgesics
Table 6. Key Players of Other Treatment
Table 7. Global Premature Ejaculation Treatment Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Premature Ejaculation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Premature Ejaculation Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Premature Ejaculation Treatment Market Share by Regions (2016-2021)
Table 11. Global Premature Ejaculation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Premature Ejaculation Treatment Market Share by Regions (2022-2027)
Table 13. Premature Ejaculation Treatment Market Trends
Table 14. Premature Ejaculation Treatment Market Drivers
Table 15. Premature Ejaculation Treatment Market Challenges
Table 16. Premature Ejaculation Treatment Market Restraints
Table 17. Global Premature Ejaculation Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Premature Ejaculation Treatment Market Share by Players (2016-2021)
Table 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Ejaculation Treatment as of 2020)
Table 20. Ranking of Global Top Premature Ejaculation Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Premature Ejaculation Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Premature Ejaculation Treatment Product Solution and Service
Table 24. Date of Enter into Premature Ejaculation Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Premature Ejaculation Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Premature Ejaculation Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Premature Ejaculation Treatment Market Size Share by Distribution Channel (2016-2021) & (US$ Million)
Table 31. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2016-2021)
Table 32. Global Premature Ejaculation Treatment Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)
Table 33. Global Premature Ejaculation Treatment Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)
Table 34. North America Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 37. North America Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 38. North America Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 43. Europe Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 44. Europe Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 49. Asia-Pacific Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 55. Latin America Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 56. Latin America Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Premature Ejaculation Treatment Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 61. Middle East & Africa Premature Ejaculation Treatment Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Premature Ejaculation Treatment Product
Table 67. Pfizer Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Premature Ejaculation Treatment Product
Table 72. Novartis Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Premature Ejaculation Treatment Product
Table 77. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 78. Eli Lilly Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Premature Ejaculation Treatment Product
Table 82. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Premature Ejaculation Treatment Product
Table 87. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 88. GlaxoSmithKline Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Premature Ejaculation Treatment Product
Table 92. Bayer Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Menarini Company Details
Table 95. Menarini Business Overview
Table 96. Menarini Premature Ejaculation Treatment Product
Table 97. Menarini Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 98. Menarini Recent Development
Table 99. Teva Company Details
Table 100. Teva Business Overview
Table 101. Teva Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 102. Teva Recent Development
Table 103. Sunrise Pharma Company Details
Table 104. Sunrise Pharma Business Overview
Table 105. Sunrise Pharma Premature Ejaculation Treatment Product
Table 106. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 107. Sunrise Pharma Recent Development
Table 108. Regent Pacific Company Details
Table 109. Regent Pacific Business Overview
Table 110. Regent Pacific Premature Ejaculation Treatment Product
Table 111. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 112. Regent Pacific Recent Development
Table 113. Torrent Pharma Company Details
Table 114. Torrent Pharma Business Overview
Table 115. Torrent Pharma Premature Ejaculation Treatment Product
Table 116. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 117. Torrent Pharma Recent Development
Table 118. Vivus Company Details
Table 119. Vivus Business Overview
Table 120. Vivus Premature Ejaculation Treatment Product
Table 121. Vivus Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
Table 122. Vivus Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premature Ejaculation Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antidepressants(SSRIs) Features
Figure 3. Phosphodiesterase-5 Inhibitors Features
Figure 4. Topical Anesthetics Features
Figure 5. Analgesics Features
Figure 6. Other Treatment Features
Figure 7. Global Premature Ejaculation Treatment Market Share by Distribution Channel: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Premature Ejaculation Treatment Report Years Considered
Figure 13. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Premature Ejaculation Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Premature Ejaculation Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Premature Ejaculation Treatment Market Share by Regions (2022-2027)
Figure 17. Global Premature Ejaculation Treatment Market Share by Players in 2020
Figure 18. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Ejaculation Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2020
Figure 20. Global Premature Ejaculation Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Premature Ejaculation Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 24. North America Premature Ejaculation Treatment Market Share by Distribution Channel (2016-2027)
Figure 25. North America Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 26. United States Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 30. Europe Premature Ejaculation Treatment Market Share by Distribution Channel (2016-2027)
Figure 31. Europe Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 32. Germany Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Premature Ejaculation Treatment Market Share by Distribution Channel (2016-2027)
Figure 41. Asia-Pacific Premature Ejaculation Treatment Market Share by Region (2016-2027)
Figure 42. China Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Premature Ejaculation Treatment Market Share by Distribution Channel (2016-2027)
Figure 51. Latin America Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Premature Ejaculation Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Premature Ejaculation Treatment Market Share by Distribution Channel (2016-2027)
Figure 57. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 67. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 68. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 69. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 70. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 71. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 72. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
  • Global Testosterone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period. The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
  • Global Finasteride Tablets Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Global Erectile Dysfunction Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
  • Global Methyltestosterone Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 75
    The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles......
  • Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Tamsulosin market: According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
  • Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Erectile Dysfunction Drug market: According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Finasteride Tablets market: According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
  • Finasteride Tablets - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 106
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
  • Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 134
    Report Overview: The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period. This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs